Overview

A Study of ATRA in the Treatment of ITP

Status:
Not yet recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
An open-label, multicenter study to compare the efficacy and safety of ATRA for the treatment of adults with primary immune thrombocytopenia (ITP)
Phase:
Phase 2
Details
Lead Sponsor:
Peking University People's Hospital
Collaborators:
Beijing Hospital
Qilu Hospital of Shandong University
The Sixth Medical Center of PLA General Hospital
Treatments:
Tretinoin